Rating Change
JP Morgan analysts initiated coverage on Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) with a Overweight rating on July 27, 2026.
new coverageNASDAQ:RYTM
JP Morgan Initiates Coverage on Rhythm Pharmaceuticals, Inc. (RYTM) with Overweight
Rating Change JP Morgan analysts initiated coverage on Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) with a Overweight rating on July 27, 2026. Market Context Rhythm Pharmaceuticals,…
Market Context
Rhythm Pharmaceuticals, Inc. operates in the Healthcare sector. The stock currently trades at $106.13 with a market capitalization of $7.8B. The stock has gained 20.6% over the past 52 weeks.
Analyst coverage from JP Morgan provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for Rhythm Pharmaceuticals, Inc..
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Recent Analyst Activity for Rhythm Pharmaceuticals, Inc.
Among the 10 most recent ratings: 10 Buy, 0 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Jul 27, 2026 | JP Morgan | Overweight | N/A |
| Jul 07, 2026 | RBC Capital | Outperform | N/A |
| Jun 16, 2026 | Canaccord Genuity | Buy | N/A |
| Jun 15, 2026 | Wells Fargo | Overweight | N/A |
| May 07, 2026 | Canaccord Genuity | Buy | N/A |
Related Tools: Analyst Ratings Dashboard | View RYTM Stock Page
Frequently Asked Questions
What does a Overweight rating mean for RYTM?
A Overweight rating from JP Morgan reflects the analyst's outlook on Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Where can I find more analyst ratings?
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the RYTM forecast page.